Stereotaxis (STXS) Change in Receivables (2010 - 2026)
Stereotaxis' (STXS) quarterly Change in Receivables came in at -$543000.0 in Q1 2026, down 208.6% year-on-year from $500000.0 in Q1 2025, and down 205.64% on a QoQ basis from $514000.0 in Q4 2025.
Stereotaxis (STXS) Change in Receivables (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Change in Receivables data on file, last reported at -$543000.0 in Q1 2026.
- On a quarterly basis, Change in Receivables fell 208.6% year-over-year to -$543000.0 in Q1 2026; TTM through Mar 2026 was $980000.0, a 404.35% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 392.76% from the prior year.
- Change in Receivables for Q1 2026 stood at -$543000.0, down from $514000.0 in the prior quarter.
- Over the last five years, Change in Receivables for STXS reached as high as $4.4 million in Q3 2024 and fell as low as -$4.1 million in Q4 2024.
- Historically, Change in Receivables has averaged -$46764.7 across 5 years, with a median of $13000.0 in 2022.
- Across the five-year window, Change in Receivables slumped 11053.85% in 2023 and surged 417.44% in 2024, its largest moves.
- Year by year, Change in Receivables stood at $13000.0 in 2022, then slumped by 11053.85% to -$1.4 million in 2023, then slumped by 187.36% to -$4.1 million in 2024, then surged by 112.56% to $514000.0 in 2025, then slumped by 205.64% to -$543000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$543000.0 in Q1 2026, $514000.0 in Q4 2025, and $940000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 146.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 16.86 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 34.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.99 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | -543,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -543,000.00 |
| Mar 31, 2026 | -543,000.00 |
| Dec 31, 2025 | 514,000.00 |
| Dec 31, 2025 | 514,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | -4.09 Mn |
| Dec 31, 2024 | -4.09 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | 131,000.00 |
| Mar 31, 2024 | 131,000.00 |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |